• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Pharma

ODAIA Secures $25M for AI-Driven Commercial Insights Platform for Pharma

by Syed Hamza Sohail 05/01/2023 Leave a Comment

ODAIA Secures $25M for AI-Driven Commercial Insights Platform for Pharma

What You Should Know: ODAIA, developers of MAPTUAL, an AI-powered commercial insights SaaS platform for pharmaceutical companies, announced it raised an oversubscribed $25 Million Series B financing round, led by Threshold Ventures and co-led by Monograph Capital. Wittington Ventures also joined, with participation from existing investors Flint Capital, BDC Capital, StandUp Ventures and Graphite Ventures. Emily Melton, Managing Partner of Threshold Ventures and Charles Conn, co-founder and
Read More

How AI Can Deliver Benefits in Healthcare Manufacturing and Patient Device Usage

by Michael Tay, Platform Lead, Rockwell Automation 05/01/2023 Leave a Comment

How AI Can Deliver Benefits in Healthcare Manufacturing and Patient Device Usage

According to Grand View Research, the global artificial intelligence (AI) in the healthcare market size was valued at USD 15.4 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 37.5% from 2023 to 2030, to reach an estimated USD 208.2 billion. That’s an impressive growth rate, indicating the expected value delivery to a mostly early-phase adoption of AI in the healthcare marketplace. With such aggressive predicted growth, many health industry professionals
Read More

Komodo Health Launches MapEnhance; Changing the Paradigm for Health Data Utilization

by Jasmine Pennic 04/27/2023 Leave a Comment

Komodo Health

What You Should Know: Komodo Health unveils MapEnhance, a network of speciality data partners that seamlessly connects new datasets — including genomic, lab, cost and clinical insights — to Komodo's Healthcare Map, to drive faster and timelier insights across healthcare and Life Sciences.With MapEnhance, Komodo is bringing the industry a more seamless way to leverage clinical intelligence and customize data inputs from a variety of real-world data sources,
Read More

1upHealth Raises $40M for FHR Data Platform

by Fred Pennic 04/12/2023 Leave a Comment

1upHealth Raises $40M for FHR Data Platform

What You Should Know: 1upHealth, a modern data platform that’s cloud-based, API-enabled, and FHIR-native today announced the close of a $40M Series C investment led by Sixth Street Growth with participation from existing investors F-Prime Capital, Jackson Square Ventures, and Eniac Ventures. Founded in 2017, 1upHealth’s FHIR®-native platform designed for interoperability and modern computing is used by over 75 enterprise organizations including leading national and
Read More

Inato Raises $20M to Make Clinical Trials More Inclusive

by Fred Pennic 03/29/2023 Leave a Comment

Inato Raises $20M to Make Clinical Trials More Inclusive

What You Should Know: - Inato, a technology platform that connects pharma companies (trial sponsors) with community-based trial sites raises $20M in new funding (A2) led by Cathay Innovation with participation from existing investor Obvious Ventures and new investors La Maison and Top Harvest Capital. Inato works with many of the top 30 pharmaceutical companies worldwide to make clinical trials more inclusive. - The new funding will fuel Inato’s continued product innovation, international
Read More

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response 

by Syed Hamza Sohail 03/29/2023 Leave a Comment

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response 

What You Should Know: Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced it raised more than $13 million in Series A financing to transform the way diseases are diagnosed and treatment decisions are made.Taiwania Capital and Debiopharm Innovation Fund co-led the round, with participation from previous investors First Star Ventures, Redalpine Venture Partners, and Pikas. Other new investors include P5 Health
Read More

Accenture Report Reveals Staggering Health Inequities and the Role of US Healthcare Ecosystem in Addressing Them 

by Syed Hamza Sohail 03/24/2023 Leave a Comment

New Accenture Report Reveals Staggering Health Inequities and the Role of US Healthcare Ecosystem in Addressing Them

What You Should Know: - Health equity – or the lack thereof – is one of the biggest challenges facing US healthcare organizations today. - A new report from Accenture, US health inequity: beyond the statistics, analyzes the role US healthcare ecosystem participants can play in addressing health inequities due to race and ethnicity. The statistics are staggering.  Analysing Key Trends Concerning Health Inequities  To understand the human and economic
Read More

Accenture: Data Collaboratives Hold Great Promise for Accelerated Healthcare Progress and Precision Medicine

by Syed Hamza Sohail 03/16/2023 Leave a Comment

Accenture: Data Collaboratives Hold Great Promise for Accelerated Healthcare Progress and Precision Medicine

What You Should Know: - Accenture published Fast-Forwarding Healthcare through Data Collaboratives Report to discover how best health ecosystem players access data to fast-forward healthcare. - Data generated by technical and scientific advances, like connected health devices, consumer health and medical-grade digital apps, individual multi-omics profiling data and the move to cloud storage, holds great promise for accelerated healthcare progress and precision medicine, and data
Read More

Protai Raises $20M to Build an Oncology Drug Discovery Pipeline

by Syed Hamza Sohail 03/15/2023 Leave a Comment

Protai Raises $20M to Build an Oncology Drug Discovery Pipeline

What You Should Know: - Protai, a proteomics and AI-powered drug discovery startup revolutionizing the way new drugs are discovered, today announced a $12 million extension of its seed round, bringing the total amount to $20M. - The round includes existing investors Grove Ventures and Pitango Healthcare and was joined by Copenhagen-based Maj Invest Equity Fund. The additional funding will be used to build Protai’s oncology drug discovery pipeline, expand data
Read More

H1 Launches Advanced Diversity and Clinical Trial Performance Insights

by Syed Hamza Sohail 03/13/2023 Leave a Comment

H1 Launches Advanced Diversity and Clinical Trial Performance Insights

What You Should Know: - H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced the availability of indication-level diversity insights in addition to institution, provider, and patient diversity data within its Trial Landscape solution. - Additionally, H1 has successfully onboarded its first customer – a top 20 pharmaceutical company – onto the H1 Data Network, a new solution that aggregates sponsor-contributed site and
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 13
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |